PKCλ in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity
Michihiro Matsumoto(Columbia University Irving Medical Center), Tetsuo Noda(Japanese Foundation For Cancer Research), Yoshitake Hayashi(Kobe University), Hitoshi Shimano(University of Tsukuba), Ryuji Hiramatsu(Sumitomo Dainippon Pharma (Japan)), Wataru Ogawa(Kobe University), Yasushi Matsuki(Sumitomo Dainippon Pharma (Japan)), Haruhisa Iguchi(Takara (Japan)), Shigeo Ohno(Juntendo University), Kensuke Furukawa(Kobe University), Masato Kasuga(The Institute of Medical Science, Asahi Life Foundation), Nobuhiro Yamada(Kindai University), Hiroshi Inoue(Tokushima University Hospital), Kazuaki Miyake(Hitachi (Japan)), Kazunori Akimoto(Tokyo University of Science)
Cited by 150
Related Papers
Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a.
|Journal of Clinical Investigation|1996|818
Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2.
|Journal of Clinical Investigation|1998|707
<i>Bacteroides vulgatus</i> and <i>Bacteroides dorei</i> Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis
|Circulation|2018|627
Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene.
|Journal of Clinical Investigation|1997|445
Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism
|Journal of Clinical Investigation|2006|436